192 related articles for article (PubMed ID: 15219933)
21. Urinary concentrating mechanism and Aquaporin-2 abundance in rats chronically treated with aluminum lactate.
Mahieu S; Millen N; Contini Mdel C; Gonzalez M; Molinas SM; Elías MM
Toxicology; 2006 Jun; 223(3):209-18. PubMed ID: 16675087
[TBL] [Abstract][Full Text] [Related]
22. [Urinary excretion of aquaporin-2 in water metabolism disorders].
Ishikawa S; Saito T; Saito T
Rinsho Byori; 1999 May; 47(5):402-7. PubMed ID: 10375960
[TBL] [Abstract][Full Text] [Related]
23. Effect of high and low sodium intake on urinary aquaporin-2 excretion in healthy humans.
Graffe CC; Bech JN; Pedersen EB
Am J Physiol Renal Physiol; 2012 Jan; 302(2):F264-75. PubMed ID: 21993890
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
[TBL] [Abstract][Full Text] [Related]
25. The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats.
Sabolić I; Katsura T; Verbavatz JM; Brown D
J Membr Biol; 1995 Feb; 143(3):165-75. PubMed ID: 7539496
[TBL] [Abstract][Full Text] [Related]
26. Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells.
Bustamante M; Hasler U; Kotova O; Chibalin AV; Mordasini D; Rousselot M; Vandewalle A; Martin PY; Féraille E
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F334-44. PubMed ID: 15494547
[TBL] [Abstract][Full Text] [Related]
27. Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells.
Hasler U; Jeon US; Kim JA; Mordasini D; Kwon HM; Féraille E; Martin PY
J Am Soc Nephrol; 2006 Jun; 17(6):1521-31. PubMed ID: 16641150
[TBL] [Abstract][Full Text] [Related]
28. Identification of vasopressin-induced genes in AQP2-transfected MDCK cells by suppression subtractive hybridization.
Kang DY; Park JI; Cho WS; Jeong MH; Cho GW; Park HT; Bae HR
Biochem Biophys Res Commun; 2004 Nov; 324(4):1234-41. PubMed ID: 15504347
[TBL] [Abstract][Full Text] [Related]
29. Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus.
Kamsteeg EJ; Stoffels M; Tamma G; Konings IB; Deen PM
Hum Mutat; 2009 Oct; 30(10):1387-96. PubMed ID: 19701945
[TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide-induced vasopressin-independent activation of aquaporin-2 in the rat kidney.
Kim S; Choi HJ; Jo CH; Park JS; Kwon TH; Kim GH
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F474-83. PubMed ID: 26109089
[TBL] [Abstract][Full Text] [Related]
31. Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans.
Buemi M; Di Pasquale G; Ruello A; Floccari F; Aloisi C; Latassa G; Corsonello A; Sturiale A; Corica F; Frisina N
Nephron; 2002 Jun; 91(2):197-202. PubMed ID: 12053053
[TBL] [Abstract][Full Text] [Related]
32. Vasopressin-regulated miRNAs and AQP2-targeting miRNAs in kidney collecting duct cells.
Kim JE; Jung HJ; Lee YJ; Kwon TH
Am J Physiol Renal Physiol; 2015 Apr; 308(7):F749-64. PubMed ID: 25651560
[TBL] [Abstract][Full Text] [Related]
33. Water immersion increases urinary excretion of aquaporin-2 in healthy humans.
Buemi M; Corica F; Di Pasquale G; Aloisi C; Sofi M; Casuscelli T; Floccari F; Senatore M; Corsonello A; Frisina N
Nephron; 2000 May; 85(1):20-6. PubMed ID: 10773751
[TBL] [Abstract][Full Text] [Related]
34. Urinary excretion of aquaporin-2 in the diagnosis of central diabetes insipidus.
Saito T; Ishikawa SE; Sasaki S; Nakamura T; Rokkaku K; Kawakami A; Honda K; Marumo F; Saito T
J Clin Endocrinol Metab; 1997 Jun; 82(6):1823-7. PubMed ID: 9177390
[TBL] [Abstract][Full Text] [Related]
35. Regulation of aquaporin-2 trafficking.
Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
[TBL] [Abstract][Full Text] [Related]
36. Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus.
Gooch JL; Guler RL; Barnes JL; Toro JJ
J Cell Sci; 2006 Jun; 119(Pt 12):2468-76. PubMed ID: 16735444
[TBL] [Abstract][Full Text] [Related]
37. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
[TBL] [Abstract][Full Text] [Related]
38. Aquaporin-2 urinary excretion in preterm infants: relationship to diuresis and vasopressin.
Iacobelli S; Gouyon JB; Bonsante F; Mastrofrancesco L; Svelto M; Valenti G
Acta Physiol (Oxf); 2010 Dec; 200(4):339-45. PubMed ID: 20618170
[TBL] [Abstract][Full Text] [Related]
39. Urinary excretion of aquaporin-2 water channel protein in chronic heart failure rats.
Xu D; Yin X; Hui H; Deng Y; Ren H
Chin Med J (Engl); 2001 Sep; 114(9):899-901. PubMed ID: 11780376
[TBL] [Abstract][Full Text] [Related]
40. The effects of intrinsic vasopressin on urinary aquaporin-2 excretion and urine osmolality during surgery under general anesthesia.
Otsuka F; Morita K; Takeuchi M; Yamauchi T; Ogura T; Sekines K; Miura M; Hirakawa M; Makino H
Anesth Analg; 1999 Jan; 88(1):181-7. PubMed ID: 9895089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
